用于分子机制研究的miRNA治疗的脂质体-lentivirus
Fen Sun1,2, Huaqing Chen2,3, Xiaoyong Dai2,4
1Institute of Animal Sciences and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, 250000, China.
Journal of nanobiotechnology
|June 10, 2024
概括
这项研究介绍了miR-145-5p-lentivirus纳米脂酶体 (MRL145) 用于肝癌干细胞 (LCSC) 治疗. MRL145通过向COL4A3,有效地抑制LCSC的自我更新和入侵,提供了一个有希望的新交付方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 纳米技术 纳米技术
背景情况:
- 癌症干细胞 (CSCs) 在固体瘤的发展和复发中至关重要.
- 微RNA-145-5p (miR-145-5p) 抑制CSC生存,但其治疗机制需要进一步阐明.
- 传统的lentivirus携带者具有有限的瘤向能力.
研究的目的:
- 开发和评估新的脂质体-晶体病毒混合纳米载体,以提高miR-145-5p向肝脏CSC (LCSC) 的传递.
- 研究miR-145-5p在LCSCs中的治疗疗效和潜在的分子机制.
主要方法:
- 构建脂质体-晶体病毒混合纳米载体 (MRL145) 用于miR-145-5p输送.
- 在体外和体内对MRL145对LCSCs的治疗作用的系统分析.
- 涉及目标基因鉴定 (COL4A3) 和途径分析 (Wnt/β-catenin,自) 的机制研究.
主要成果:
- MRL145显示出高传递效率和强大的抗瘤疗效对LCSCs.
- 过度表达的miR-145-5p通过向原蛋白IV型α3链 (COL4A3) 来显著抑制LCSC自我更新,迁移和入侵.
- 发现,通过非激活GSK3β,激活Wnt/β-catenin通路,并通过GSK3β/Gli3/VMP1轴减弱自,可促进LCSC进展.
结论:
- 这项研究为miR-145-5p的抗CSC作用提供了新的见解.
- 脂质体病毒混合纳米载体代表了癌症治疗中miRNA输送的有希望的平台.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


